Cargando…
Scientific barriers to developing vaccines against avian influenza viruses
The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with va...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097526/ https://www.ncbi.nlm.nih.gov/pubmed/17363960 http://dx.doi.org/10.1038/nri2054 |
_version_ | 1783511015202226176 |
---|---|
author | Subbarao, Kanta Joseph, Tomy |
author_facet | Subbarao, Kanta Joseph, Tomy |
author_sort | Subbarao, Kanta |
collection | PubMed |
description | The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with vaccines against human influenza viruses, researchers face several additional challenges in developing human vaccines against avian influenza viruses. In this Review, we discuss the features of avian influenza viruses, the gaps in our understanding of infections caused by these viruses in humans and of the immune response to them that distinguishes them from human influenza viruses, and the current status of vaccine development. |
format | Online Article Text |
id | pubmed-7097526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70975262020-03-26 Scientific barriers to developing vaccines against avian influenza viruses Subbarao, Kanta Joseph, Tomy Nat Rev Immunol Article The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with vaccines against human influenza viruses, researchers face several additional challenges in developing human vaccines against avian influenza viruses. In this Review, we discuss the features of avian influenza viruses, the gaps in our understanding of infections caused by these viruses in humans and of the immune response to them that distinguishes them from human influenza viruses, and the current status of vaccine development. Nature Publishing Group UK 2007-03-16 2007 /pmc/articles/PMC7097526/ /pubmed/17363960 http://dx.doi.org/10.1038/nri2054 Text en © Nature Publishing Group 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Subbarao, Kanta Joseph, Tomy Scientific barriers to developing vaccines against avian influenza viruses |
title | Scientific barriers to developing vaccines against avian influenza viruses |
title_full | Scientific barriers to developing vaccines against avian influenza viruses |
title_fullStr | Scientific barriers to developing vaccines against avian influenza viruses |
title_full_unstemmed | Scientific barriers to developing vaccines against avian influenza viruses |
title_short | Scientific barriers to developing vaccines against avian influenza viruses |
title_sort | scientific barriers to developing vaccines against avian influenza viruses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097526/ https://www.ncbi.nlm.nih.gov/pubmed/17363960 http://dx.doi.org/10.1038/nri2054 |
work_keys_str_mv | AT subbaraokanta scientificbarrierstodevelopingvaccinesagainstavianinfluenzaviruses AT josephtomy scientificbarrierstodevelopingvaccinesagainstavianinfluenzaviruses |